Market Capitalization of Parmax Pharma (PARMAX)
As of April 13, 2026, Parmax Pharma (PARMAX) market capitalisation is ₹11.69 Cr ($1.30M), with 37.69 L shares outstanding at a current price of ₹31.02 on BSE, ranking 4603 out of 5115 companies by market cap in our screener. Parmax Pharma operates in the Healthcare sector and is classified as a Small Cap stock. For live price, earnings and the complete company profile, see Parmax Pharma share price today.
Market Cap History of Parmax Pharma (Last 10 Years)
PARMAX market capitalisation from year-end BSE closing prices over the last 10 years. Read PARMAX dividend payout details for the complete payout history and dividend yield track record.
End of Year Market Cap History — Parmax Pharma
PARMAX year-end market cap in INR and USD with closing share price and annual change — BSE closing prices. See PARMAX P/B ratio to compare market price against book value per share.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹11.69 Cr
$1.30M USD
|
₹31.02 | BSE | -8.31% |
| 2025 |
₹12.75 Cr
$1.42M USD
|
₹33.83 | BSE | -23.55% |
| 2024 |
₹16.68 Cr
$1.85M USD
|
₹44.25 | BSE | +35.86% |
| 2023 |
₹12.27 Cr
$1.36M USD
|
₹32.57 | BSE | -15.84% |
| 2022 |
₹14.58 Cr
$1.62M USD
|
₹38.70 | BSE | -35.45% |
| 2021 |
₹22.59 Cr
$2.51M USD
|
₹59.95 | BSE | +103.22% |
| 2020 |
₹11.12 Cr
$1.24M USD
|
₹29.50 | BSE | +63.89% |
| 2019 |
₹6.78 Cr
$753,707 USD
|
₹18.00 | BSE | +4.05% |
| 2018 |
₹6.52 Cr
$724,396 USD
|
₹17.30 | BSE | +1.76% |
| 2017 |
₹6.41 Cr
$711,835 USD
|
₹17.00 | BSE | - |